Related Experiment Video

Updated: Jun 25, 2026

Rat Model of Blood-brain Barrier Disruption to Allow Targeted Neurovascular Therapeutics
08:43

Rat Model of Blood-brain Barrier Disruption to Allow Targeted Neurovascular Therapeutics

Published on: November 30, 2012

AAV9: a potential blood-brain barrier buster

Fredric P Manfredsson1, Aaron C Rising, Ronald J Mandel

  • 1Department of Neuroscience, Powell Gene Therapy Center, McKnight Brain Institute, University of Florida College of Medicine, Gainesville, Florida 32610, USA.

Molecular Therapy : the Journal of the American Society of Gene Therapy
|February 28, 2009
PubMed
Summary

No abstract available in PubMed .

More Related Videos

An In Vivo Blood-brain Barrier Permeability Assay in Mice Using Fluorescently Labeled Tracers
09:35

An In Vivo Blood-brain Barrier Permeability Assay in Mice Using Fluorescently Labeled Tracers

Published on: February 26, 2018

A Benchtop Approach to the Location Specific Blood Brain Barrier Opening using Focused Ultrasound in a Rat Model
08:58

A Benchtop Approach to the Location Specific Blood Brain Barrier Opening using Focused Ultrasound in a Rat Model

Published on: June 13, 2020

Related Experiment Videos

Last Updated: Jun 25, 2026

Rat Model of Blood-brain Barrier Disruption to Allow Targeted Neurovascular Therapeutics
08:43

Rat Model of Blood-brain Barrier Disruption to Allow Targeted Neurovascular Therapeutics

Published on: November 30, 2012

An In Vivo Blood-brain Barrier Permeability Assay in Mice Using Fluorescently Labeled Tracers
09:35

An In Vivo Blood-brain Barrier Permeability Assay in Mice Using Fluorescently Labeled Tracers

Published on: February 26, 2018

A Benchtop Approach to the Location Specific Blood Brain Barrier Opening using Focused Ultrasound in a Rat Model
08:58

A Benchtop Approach to the Location Specific Blood Brain Barrier Opening using Focused Ultrasound in a Rat Model

Published on: June 13, 2020

Related Concept Videos

The Blood-brain Barrier00:49

The Blood-brain Barrier

Overview
Physiological Barriers01:25

Physiological Barriers

Physiological barriers are semi-permeable cellular structures restricting drug diffusion into intracellular compartments and tissues. There are six types of physiological barriers: blood endothelial, cell membrane, blood-brain, blood-cerebrospinal fluid (CSF), blood-placenta, and blood-testis barriers.
The blood endothelial barrier is the most porous of these. It allows all small ionized, un-ionized, and lipophilic molecules to pass through the endothelial lining into the interstitial space...

Articles linked to this work by shared authors, journal, and citation graph.

Construct optimization for AAV-mediated human α-syn overexpression, and validation across research settings: Development of a shared tool for the research community.

Journal of Parkinson's disease·2026

Tau, amyloid-β and α-synuclein co-pathologies synergistically enhance neuroinflammation and hippocampal neuron loss.

Neurobiology of disease·2026

Gene therapy for Parkinson's disease-Ample room for optimism.

Current opinion in neurobiology·2025

Tau, amyloid-β and α-synuclein co-pathologies synergistically enhance neuroinflammation and neuropathology.

bioRxiv : the preprint server for biology·2025

Physics of Protein Aggregation in Normal and Accelerated Brain Aging.

BioEssays : news and reviews in molecular, cellular and developmental biology·2025

Alterations in functional and structural connectivity in the 6-OHDA-induced Parkinsonian rat model.

Frontiers in neuroscience·2025

Addressing the package: Cell-specific gene delivery using lentiviral vectors.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

DDX3X overexpression in mice can cause rapid tissue-specific toxicity and mortality.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

Multivalent DNA vaccines induce potent cellular responses and prolong BCG-mediated control of Mycobacterium tuberculosis.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

Recent Progress in the Rational Design of mRNA Vaccines.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

In vivo-directed evolution identifies AAV-WM04 as a next-generation vector for potent and sustained hearing restoration in DFNB9.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

miR-146a Mimic Therapy Protects Against Platelet-Mediated Thrombosis.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

Microbiota-gut-brain axis imbalance: a promising therapeutic target for preserving brain health in high-altitude environment.

Frontiers in neuroscience·2026

A dual-prototype morphological topology evolution network for clinically oriented brain tumor MRI segmentation.

Frontiers in oncology·2026

Nose-to-brain delivery of candesartan-loaded nanoemulsion: brain biodistribution and neurobehavioral outcomes in controlled cortical impact-induced traumatic brain injury.

Inflammopharmacology·2026

Enhancing brain delivery of tegaserod for Alzheimer's disease: a pharmaceutical comparison of two nanocarrier-based strategies.

International journal of pharmaceutics·2026

Design and in silico validation of donor DNA for RNA-guided recombinase-mediated knockout of mstnb gene in Labeo rohita.

PloS one·2026

Prediction of migraine treatment response with clinical and genetic data: A machine learning analysis of the HUNT study.

Cephalalgia : an international journal of headache·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us